↧
FDA approves Zepbound for sleep apnea
The U.S. Food and Drug Administration (FDA) recently approved Zepbound (tirzepatide) as the first prescription drug for obstructive sleep apnea. Zepbound was first approved for chronic weight...
View ArticleFDA approves first generic once-daily GLP-1 medication
As glucagon-like peptide-1 (GLP-1) receptor agonists continue to surge in popularity, the U.S. Food and Drug Administration approved the second generic in this class of medications: liraglutide...
View Article